comparemela.com

Page 2 - Implants Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-News: aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028

EQS-News: aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United statesFrankfurt stock exchangeImplants incRegulated marketGeneral standardExecutive boardRubino di girolamo

Aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028

EQS-News: aap Implantate AG / Key word: Financing aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028.

United statesImplants incFrankfurt stock exchangeRegulated marketGeneral standardExecutive boardRubino di girolamo

After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year

EQS-News: aap Implantate AG / Key word: Interim Report/Corporate Action After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year 15.02.2024.

Standard of the frankfurt stock exchangeHealth research framework programImplants incGerman federal ministry of educationNotified bodyGerman federal ministryHealth research frameworkRegulated marketGerman stock exchangesGeneral standardFrankfurt stock exchangeManagement boardRubino di girolamo

EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year

EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

German federal ministry of educationImplants incHealth research framework programStandard of the frankfurt stock exchangeNotified bodyGerman federal ministryHealth research frameworkRegulated marketGerman stock exchangesGeneral standardFrankfurt stock exchangeManagement boardRubino di girolamo

More than 100 patients included in the human clinical trial by 31 December 2023; adapted study desig

EQS-Media / 10.01.2024 / 07:30 CET/CESTWith regard to its innovative antibacterial implant technology, aap was able to successfully accelerate recruitment in the ongoing human clinical trial with the adapted study design in the course of 2023 and has already successfully recruited more than 100 patients by 31 Decemb.

United statesImplants incDistribution servicesMinistry of educationFrankfurt stock exchangeHealth research framework programFederal ministryResearch framework programRegulated marketGeneral standardExecutive boardRubino di girolamoPress releaseRegulatory announcementsCorporate news

vimarsana © 2020. All Rights Reserved.